Inovio Pharmaceuticals Inc (INO)

[Lakers_w]

Solidarity Trial Picks Two COVID-19 Vaccine Candidates
October 27, 2021 • 5:40 am CDT

The WHO and the Ministries of Health of Colombia, Mali, and the Philippines announced on October 26, 2021, the launch of the co-sponsored Solidarity Trial Vaccines in over 40 trial sites.

This international, randomized clinical trial platform is designed to rapidly evaluate the efficacy and safety of promising COVID-19 vaccine candidates selected by an independent vaccine prioritization advisory group composed of leading scientists and experts.

To date, the independent vaccine prioritization advisory group has reviewed the evidence of around 20 candidate vaccines.

Following the recommendation of the working group, two candidate vaccines are now included in the Solidarity Trial Vaccines, that are as follows:

A protein subunit vaccine from Medigen (MVC-COV1901) located in Taiwan, and
A DNA vaccine encoding the spike protein from Inovio (INO-4800) located in Pennsylvania.

Two additional vaccines are expected to enter the Solidarity Trial Vaccines once further evidence and documentation has been reviewed and accepted as satisfactory by the independent vaccine prioritization advisory group.

It is expected that other candidate vaccines currently under consideration by the vaccine prioritization advisory group may be added to the trial in late 2021 and during 2022.

The Solidarity Trial Vaccines have the additional potential to uncover second-generation vaccines with greater efficacy, conferring greater protection against variants of concern, offering a longer duration of protection, and/or using needle-free routes of administration.

https://www.google.com/amp/s/www.precisionvaccinations.com/2021/10/27/solidarity-trial-picks-two-covid-19-vaccine-candidates%3famp